Cao et al., 2001 - Google Patents
Design of a self-regulated drug delivery deviceCao et al., 2001
- Document ID
- 16015475974309964888
- Author
- Cao X
- Lai S
- James Lee L
- Publication year
- Publication venue
- Biomedical Microdevices
External Links
Snippet
Most conventional drug delivery systems are based on polymers or lipid vesicles. These chemically synthesized materials can be designed to be biocompatible and have good functionality, but they often lack well-defined properties, due to an inherent size and …
- 230000001105 regulatory 0 title abstract description 13
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cao et al. | Design of a self-regulated drug delivery device | |
| US5226902A (en) | Pulsatile drug delivery device using stimuli sensitive hydrogel | |
| Tao et al. | Microfabricated drug delivery systems: from particles to pores | |
| US4705503A (en) | Metabolite sensor including a chemical concentration sensitive flow controller for a drug delivery system | |
| Siegel et al. | Mechanochemical approaches to self-regulating insulin pump design | |
| US5062841A (en) | Implantable, self-regulating mechanochemical insulin pump | |
| Leoni et al. | Characterization of nanoporous membranes for immunoisolation: Diffusion properties and tissue effects | |
| Kim et al. | Self-regulated glycosylated insulin delivery | |
| Leoni et al. | Nanoporous biocapsules for the encapsulation of insulinoma cells: biotransport and biocompatibility considerations | |
| Mayer | Nanocapsules as drug delivery systems | |
| Traitel et al. | Smart polymers for responsive drug-delivery systems | |
| Cartier et al. | Glucose-sensitive membrane coated porous filters for control of hydraulic permeability and insulin delivery from a pressurized reservoir | |
| US9907906B2 (en) | Systems, methods, and devices for in vivo delivery using remote actuation of implantable hydrogel MEMS devices | |
| Wu et al. | A fluorescent responsive hybrid nanogel for closed-loop control of glucose | |
| Dupuy et al. | In situ polymerization of a microencapsulating medium round living cells | |
| CN102258498B (en) | Release mass transfer rate adjustable and controllable intelligent drug delivery carrier and preparation method thereof | |
| KR101068499B1 (en) | Method for preparing temperature and pH sensitive hydrogel | |
| Goldraich et al. | Glucose-sensitive polymeric matrices for controlled drug delivery | |
| WO1989001794A1 (en) | Metabolic sensor for a drug delivery system | |
| Dembczynski et al. | Determination of pore diameter and molecular weight cut-off of hydrogel-membrane liquid-core capsules for immunoisolation | |
| Siddiqa et al. | Preparation of letrozole dispersed pHEMA/AAm-g-LDPE drug release system: In-vitro release kinetics for the treatment of endometriosis | |
| CN110769811A (en) | Device for transdermal delivery of active molecules, use of the device and method for producing the device and components thereof | |
| JP2009544393A (en) | Drug delivery system with heat-switchable membrane | |
| JPH0285216A (en) | Non-uniform mutual penetration polymer reticulated structure for releasing drug in controlled manner | |
| Peppas et al. | Glucose-responsive hydrogels |